Overview Request Sample Pages Request Customization Download PDF
You are viewing: UK Blood Collection Devices Market analysis

The UK Blood Collection Devices Market was valued at $108 Million in 2025 and projected to reach to $161.1 Million by 2030, representing a compound annual growth rate of 8.3%. The UK blood collection devices market is experiencing robust expansion driven by NHS modernization efforts and increased diagnostic testing demand.

UK Blood Collection Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Blood Collection Devices Market Trends and Insights

  • The UK market is driven by increasing demand for diagnostic testing, rising prevalence of chronic diseases, and modernization of healthcare infrastructure across the nation.
  • The UK's robust National Health Service (NHS) framework and emphasis on preventive care continue to support steady adoption of advanced blood collection technologies. In the UK, growth is further accelerated by aging demographics and heightened awareness of blood safety protocols.
  • The UK market benefits from strong regulatory standards and investment in laboratory automation, which enhance efficiency in blood collection procedures.
  • Between 2025 and 2030, the UK is expected to see significant uptake of safety-engineered devices and integrated collection systems, positioning the country as a key market within Europe's broader healthcare landscape..

Key Market Statistics

  • CAGR (2025-2030) 8.3% CAGR
  • Market Size, 2025 ~USD 108 Million
  • Forecast, 2030 ~USD 161.1 Million
  • Country UK

UK Blood Collection Devices Market Overview

Market Valuation :

The UK blood collection devices market is valued at $108.0 million in 2025 and is projected to reach $161.1 million by 2030, demonstrating strong growth potential in the healthcare sector.

NHS-Driven Demand :

The UK's National Health Service (NHS) modernization initiatives and increased investment in diagnostic infrastructure are driving significant demand for advanced blood collection technologies across hospitals and primary care facilities.

Chronic Disease Prevalence :

Rising prevalence of chronic diseases including diabetes, cardiovascular conditions, and cancer in the UK population is increasing the frequency of diagnostic blood testing and collection procedures.

Regulatory Environment :

Stringent UK and European regulatory standards ensure high-quality blood collection devices, creating opportunities for manufacturers meeting MHRA and CE marking requirements.

UK Blood Collection Devices Market Dynamics

  • With an 8.3% CAGR through 2030, the market benefits from aging demographics, rising chronic disease prevalence, and healthcare infrastructure investments.
  • The UK's emphasis on preventive care and early disease detection is accelerating adoption of advanced collection technologies.
  • Additionally, integration of digital health solutions and automation in laboratory settings is creating new opportunities for innovative device manufacturers and suppliers..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • The UK blood collection devices market is valued at $108.0 million in 2025 and will reach $161.1 million by 2030, growing at 8.3% CAGR.
      • The UK's NHS infrastructure and preventive care focus drive consistent demand for advanced blood collection technologies.
      • Safety-engineered devices and laboratory automation are key growth drivers in the UK market through 2030.
      • The UK's aging population and stringent regulatory standards support sustained market expansion and innovation.

      Blood Collection Devices Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment PLASMA/WHOLE BLOOD TUBES (Type)
      Forecast Period 2025–2030
      Growth Rate CAGR of 7.4% from 2025 to 2030
      Largest Segment MANUAL BLOOD COLLECTION (Method)
      Market Size Base Year (Billions) ~USD 9.11 (2025)
      Revenue Forecast (Billions) ~USD 13.02 (2030)
      Segments Covered Product, Type, System Type, Method, Application, End User

      UK Blood Collection Devices Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product

      • Blood Bags
      • Blood Collection Systems/ Monitors
      • Blood Collection Tubes
      • Lancets
      • Needle & Syringes

      By Type

      • Coagulation Tubes
      • Edta Tubes
      • Esr Tubes
      • Glucose Tubes
      • Heparin Tubes
      • Plasma/Whole Blood Tubes
      • Serum Tubes

      By System Type

      • Non-Vacuum Type
      • Vacuum Type

      By Method

      • Automated Blood Collection
      • Manual Blood Collection

      By Application

      • Diagnostic Applications
      • Therapeutic Applications

      By End User

      • Blood Banks
      • Diagnostic & Pathology Labs
      • Hospitals, Ambulatory Surgical Centers, And Nursing Homes
      • Other End Users

      UK: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      BLOOD BANKS51.654.657.360.463.96872.577.76.3
      DIAGNOSTIC & PATHOLOGY LABS69.574.679.484.991.298.3106.4115.67.8
      HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES166.1179.8192.9207.8225244.4266.6291.78.6
      OTHER END USERS18.919.920.821.82324.325.827.55.7
      TOTAL306.1329350.5374.8403435471.3512.57.9

      Target Audience

      • Medical Device Manufacturers : Manufacturers need UK-specific market data to develop localized product strategies, understand NHS procurement processes, and identify opportunities for market entry or expansion in blood collection technologies.
      • Healthcare Distributors & Suppliers : Distributors require detailed market insights to optimize inventory management, negotiate supplier contracts, and identify growth segments within the UK healthcare supply chain.
      • NHS Trust Procurement Teams : NHS procurement professionals need market analysis to benchmark pricing, evaluate supplier capabilities, and make informed purchasing decisions for blood collection device contracts.
      • Private Healthcare Operators : Private hospital and diagnostic laboratory operators need competitive intelligence to differentiate service offerings, optimize operational efficiency, and capture market share in the UK's growing private healthcare sector.
      • Healthcare Investors & Consultants : Investment firms and management consultants require comprehensive market data to assess investment opportunities, evaluate acquisition targets, and develop strategic recommendations for healthcare sector clients.

      Key Companies in the UK Blood Collection Devices Market

      CompanyHQOwnershipStrongest segments
      ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyTurnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions,
      ABBOTT LABORATORIESUnited StatesPublic CompanyMedical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula),
      NOLATOSwedenPublic CompanyMedical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC),
      QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables),
      GRIFOLS, S.A.SpainPublic CompanyBiopharma (plasma-derived medicines),Diagnostic,Bio Supplies,
      NIPRO CORPORATIONJapanPublic CompanyRenal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components),
      HAEMONETICS CORPORATIONUnited StatesPublic CompanyPlasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+),
      ICU MEDICAL, INC.United StatesPublic CompanyInfusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware,
      CARDINAL HEALTHUnited StatesPublic CompanyBranded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands),
      RETRACTABLE TECHNOLOGIES, INC.United StatesPublic CompanyVanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps,
      AB MEDICAL CO., LTD.IrelandPublic CompanyCardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio,

      ATS AUTOMATION TOOLING SYSTEMS INC

      ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

      ABBOTT LABORATORIES

      Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.

      NOLATO

      Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.

      QIAGEN NV

      QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.

      DANAHER CORPORATION

      Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.

      GRIFOLS, S.A.

      Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.

      NIPRO CORPORATION

      Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.

      HAEMONETICS CORPORATION

      Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.

      ICU MEDICAL, INC.

      ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.

      CARDINAL HEALTH

      Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.

      RETRACTABLE TECHNOLOGIES, INC.

      Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.

      AB MEDICAL CO., LTD.

      AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.

      Reasons to Buy this Report

      • NHS Market Penetration Strategy : Understand the specific procurement requirements and tender processes of NHS trusts and primary care networks to effectively position products and services within the UK's largest healthcare buyer.
      • Competitive Landscape Intelligence : Gain detailed insights into UK-based and international competitors operating in the blood collection devices sector, including market share analysis and competitive positioning strategies.
      • Regulatory Compliance Roadmap : Access comprehensive guidance on MHRA approval pathways, CE marking requirements, and UK-specific regulatory standards essential for product launches and market expansion.
      • Growth Opportunity Identification : Identify high-growth segments within the UK market including point-of-care testing, automation solutions, and specialty collection devices aligned with NHS modernization priorities.
      • Regional Market Dynamics : Analyze regional variations across England, Scotland, Wales, and Northern Ireland to tailor go-to-market strategies and identify underserved healthcare regions with expansion potential.

      Frequently asked questions

      What is the current size of the UK blood collection devices market?

      The UK blood collection devices market is valued at $108.0 million in 2025.

      What is the projected market size for the UK by 2030?

      The UK blood collection devices market is projected to reach $161.1 million by 2030.

      What is the growth rate of the UK blood collection devices market?

      The UK market is growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2030.

      What factors are driving growth in the UK blood collection devices market?

      Key drivers include increasing diagnostic testing demand, rising chronic disease prevalence, NHS modernization, aging demographics, and investment in laboratory automation across the UK.

      Which product types are gaining traction in the UK market?

      Safety-engineered devices and integrated collection systems are experiencing significant uptake in the UK market between 2025 and 2030.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      The following is a breakdown of the primary respondents:

      Blood Collection Devices Market

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Blood Collection Devices Market

      Data Triangulation

      The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.

      Stakeholders

      • Healthcare Service Providers (Hospitals and Pathology Centers)
      • Blood Collection Product Manufacturers
      • Blood Banks
      • Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
      • To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
      • To profile the key players in the market and comprehensively analyze their market positions and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market

       

      Get the Full Blood Collection Devices Market Report

      Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status